Hepregen Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
Hepregen General Information
Description
Developer of bio-engineering technology designed to transform safety assessment and drug development. The company's technology is used to build a bio-engineered micro-liver platform for use in a range of applications, including metabolite identification, toxicity screening, clearance, drug-drug interactions and transporter involvement, enabling physicians to have validated pharmaceuticals products.
Contact Information
Website
www.hepregen.comCorporate Office
- 200 Boston Avenue
- Suite 1500
- Medford, MA 02155
- United States
Corporate Office
- 200 Boston Avenue
- Suite 1500
- Medford, MA 02155
- United States
Hepregen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Merger/Acquisition | 06-Nov-2015 | Completed | Generating Revenue | |||
| 9. Grant | 27-Jun-2012 | Completed | Generating Revenue | |||
| 8. Grant | 25-May-2011 | Completed | Startup | |||
| 7. Accelerator/Incubator | 01-Jan-2011 | Completed | Startup | |||
| 6. Grant | 13-Jan-2010 | Completed | Startup | |||
| 5. Grant | 01-Sep-2009 | Completed | Startup | |||
| 4. Grant | 01-Mar-2009 | Completed | Startup | |||
| 3. Early Stage VC (Series A) | 25-Feb-2009 | Completed | Startup | |||
| 2. Spin-Off | 02-Sep-2008 | Completed | Startup | |||
| 1. Grant | 01-Sep-2008 | $200K | Completed | Startup |
Hepregen Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Hepregen Comparisons
Industry
Financing
Details
Hepregen Competitors (22)
One of Hepregen’s 22 competitors is Nabla Bio, a Venture Capital-Backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Nabla Bio | Venture Capital-Backed | Cambridge, MA | ||||
| Samsung Bioepis | Corporate Backed or Acquired | Incheon, South Korea | ||||
| Biocon Biologics | Formerly PE-Backed | Bengaluru, India | ||||
| Generate Biomedicines | Formerly VC-backed | Somerville, MA | ||||
| Siegfried Holding | Corporation | Zofingen, Switzerland |
Hepregen Patents
Hepregen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20130266939-A1 | Systems and methods for studying inflammation-drug interactions | Inactive | 12-Mar-2012 | ||
| WO-2013138348-A1 | Systems and methods for studying inflammation-drug interactions | Inactive | 12-Mar-2012 | ||
| WO-2012099787-A1 | Systems and methods for micro-contact stamping | Inactive | 21-Jan-2011 | C12M33/02 |
Hepregen Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Battelle Ventures | Venture Capital | Minority | ||
| Catalyst Health Ventures | Venture Capital | Minority | ||
| Innovation Valley Partners | Venture Capital | Minority | ||
| Springboard Enterprises | Accelerator/Incubator | Minority | ||
| US National Science Foundation | Accelerator/Incubator |
Hepregen FAQs
-
When was Hepregen founded?
Hepregen was founded in 2007.
-
Where is Hepregen headquartered?
Hepregen is headquartered in Medford, MA.
-
What industry is Hepregen in?
Hepregen’s primary industry is Biotechnology.
-
Is Hepregen a private or public company?
Hepregen is a Private company.
-
What is Hepregen’s current revenue?
The current revenue for Hepregen is .
-
How much funding has Hepregen raised over time?
Hepregen has raised $5.16M.
-
Who are Hepregen’s investors?
Battelle Ventures, Catalyst Health Ventures, Innovation Valley Partners, Springboard Enterprises, and US National Science Foundation have invested in Hepregen.
-
Who are Hepregen’s competitors?
Nabla Bio, Samsung Bioepis, Biocon Biologics, Generate Biomedicines, and Siegfried Holding are some of the 22 competitors of Hepregen.
-
When was Hepregen acquired?
Hepregen was acquired on 06-Nov-2015.
-
Who acquired Hepregen?
Hepregen was acquired by Ascendance Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process